Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy
Trial ID or NCT#
NCT00725387
Status
NOT RECRUITING
Purpose
Fluorine-18 Fluorodeoxyglucose (F-18 FDG) PET/CT is established as a powerful imaging tool for cancer detection and monitoring response to therapy. Sodium Fluorine-18 (F-18) was used in the 1970s for bone scanning and can be used as a skeletal tracer in current PET/CT scanners. The combined administration of F-18 and F-18 FDG in a single PET/CT scan for cancer detection was not attempted to date. We hope to learn what is the best approach for detection of cancer and thus to improve cancer treatment.
Official Title
Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
- * Patients older than 18-year-old, diagnosed with cancer* Patients must understand and voluntarily sign an Informed Consent form after the contents have been fully explained to them
Exclusion Criteria:
- * Patients who cannot complete a PET/CT scan* Pregnant women* Healthy volunteers* Patients participating in other ÌÇÐÄ´«Ã½ studies
- The subjects will not be paid to participate in this protocol. No costs will be charged to the subjects.
Investigator(s)
Sanjiv Sam Gambhir, MD, PhD
Contact us to find out if this trial is right for you.
Contact
Andrei Iagaru
650-736-2859
View on